XRAYS Quarterly Digest

XRAYS: Making Sense of Cancer Headlines
Fall Edition

XRAYS Quarterly Digest For Summer 2019

A compilation of the past quarter's reviewed articles.

FORCE's eXamining the Relevance of Articles for Young Survivors (XRAYS) program, is a reliable resource designed to help young breast cancer survivors and high-risk women navigate through breast cancer research related news and information

XRAYS study XRAYS Rating

STUDY: Does eating meat affect breast cancer risk?

Eating meat has been suggested to increase breast cancer risk. The recent Sister Study looked at meat type, cooking methods and breast cancer risk in a study of 42,012 women.  (9/10/19)

XRAYS study XRAYS Rating

STUDY: Is it safe for BRCA mutation carriers to become pregnant following breast cancer?

New research shows that pregnancy after breast cancer is safe for women with BRCA mutations and their babies. (9/4/19)

XRAYS study XRAYS Rating

STUDY: Supportive care can improve quality of life for people with metastatic breast cancer

Metastatic breast cancer patients have unique needs for treatment and care. Connecting patients to appropriate support services and palliative care is an area of need in health care. A recent study reported improvement in metastatic breast cancer patient quality of life and wellness with an intervention program called the Supportive, Education and Advocacy (MBC-SEA) program. (8/21/19)

XRAYS study XRAYS Rating

STUDY: MRI or mammograms for detecting breast cancer in families with unknown genetic mutations?

MRI and mammograms are used together to detect breast cancer in high-risk women who test positive for a BRCA or other gene mutation that increases the risk for breast cancer. For women with a family history of breast cancer but no known genetic mutation, increased screening is recommended. But what method is best? A recent clinical trial in the Netherlands compared MRI and mammography for this population. (8/15/19)

XRAYS study XRAYS Rating

STUDY: Diagnosis and treatment delays in young women with breast cancer

Young women are more likely to have delays in a breast cancer diagnosis and treatment.  Factors that affect these delays include pregnancy, breastfeeding, financial concerns and having a family history of breast or ovarian cancer. (8/5/19)

XRAYS guideline XRAYS Rating

GUIDELINE: FDA asks Allergan to recall certain textured breast implants

On July 25, 2019, the Food and Drug Administration requested that breast implant manufacturer Allergan recall its BIOCELL textured implants and expanders due to an association with a rare type of lymphoma called Breast Implant Associated Anaplastic Large Cell Lymphoma or BIA-ALCL. The FDA does not recommend removing implants for people who do not have disease symptoms. This XRAYS review updates information about this FDA recall. (7/29/19)

XRAYS study XRAYS Rating

STUDY: CDK inhibitors may increase survival for ER-positive metastatic breast cancer patients

The phase III MONALEESA-7 study is a clinical trial looking at the effect of a type of treatment known as a CDK4/6 inhibitor in pre- or perimenopausal women with hormone receptor–positive advanced breast cancer. (7/22/19) 



XRAYS study XRAYS Rating

STUDY: Results from the POLO trial: Olaparib may delay cancer progression in metastatic pancreatic cancer patients with BRCA mutations.

The POLO clinical trial looks at whether the PARP inhibitor olaparib improves outcomes for those with metastatic pancreatic cancer after platinum-based chemotherapy.  (7/3/19)

XRAYS study XRAYS Rating

STUDY: LGBTQ patients recommend improvements for their cancer care

Little is known about the cancer care experiences of lesbian, gay, bisexual, transgender and queer (LGBTQ) patients. This study looks at recommendations from the LGBTQ community for improving their cancer care. (6/20/19)

FORCE:Facing Our Risk of Cancer Empowered